Hamid Gari, PhD
Hamid is the VP of Diagnostics New Ventures for Danaher Corporation.
Prior to joining Danaher, Hamid served in strategic leadership and business development roles at Roche. He was also a partner at Avicenna Medical Systems, a digital health company, and headed a business unit for strategic intelligence company Deallus.
Hamid holds a PhD in Cancer Biology from the University of Colorado and received his MBA from the University of Cambridge.